Mycoprotein Market (By Type: Feed Grade Mycoprotein Food Grade Mycoprotein; By Form: Minced Slices; By Sales Channel: Supermarkets/Hyper Markets Convenience Stores Specialty Stores Online Stores) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Mycoprotein Market
5.1. COVID-19 Landscape: Mycoprotein Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Mycoprotein Market, By Type
8.1. Mycoprotein Market Revenue and Volume, by Type, 2024-2033
8.1.1 Feed Grade Mycoprotein
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Food Grade Mycoprotein
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Mycoprotein Market, By Form
9.1. Mycoprotein Market Revenue and Volume, by Form, 2024-2033
9.1.1. Minced
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Slices
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Mycoprotein Market, By Sales Channel
10.1. Mycoprotein Market Revenue and Volume, by Sales Channel, 2024-2033
10.1.1. Supermarkets/Hyper Markets
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Convenience Stores
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Specialty Stores
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Online Stores
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Mycoprotein Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
Chapter 12. Company Profiles
12.1. Enough
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Tempty Foods
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. The Better Meat Co.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Quorn Foods
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Symrise
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Mycorena AB
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. An ACME Group Company
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Bright Green Partners B.V.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. KIDEMIS GmbH
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Mycovation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client